Alice Ho

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy
    Alice Y Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Med Dosim 39:18-22. 2014
  2. pmc Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
    Marsha Reyngold
    Department of Radiation Oncology, Memorial Sloan Kettering, 1275 York Ave, New York, NY 10065, USA
    Radiat Oncol 8:99. 2013
  3. doi request reprint Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy
    Alice Y Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 118:4944-52. 2012
  4. doi request reprint Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation
    Alice Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 118:2552-9. 2012
  5. doi request reprint The effect of age in the outcome and treatment of older women with ductal carcinoma in situ
    Alice Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Breast 20:71-7. 2011
  6. doi request reprint Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment
    Sarah Milgrom
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:3762-70. 2012
  7. doi request reprint Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection
    Jeremy Setton
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 118:1994-2003. 2012
  8. ncbi request reprint Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes
    Tracy Ann Moo
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:3169-74. 2013
  9. doi request reprint Patterns of utilization of adjuvant radiotherapy and outcomes in black women after breast conservation at a large multidisciplinary cancer center
    Sophia M Edwards-Bennett
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 80:1102-8. 2011
  10. doi request reprint Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer
    Ana P Kiess
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 118:1982-8. 2012

Collaborators

Detail Information

Publications16

  1. doi request reprint Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy
    Alice Y Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Med Dosim 39:18-22. 2014
    ..Refinement of radiation techniques in reconstructed patients who require comprehensive nodal irradiation is warranted. ..
  2. pmc Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
    Marsha Reyngold
    Department of Radiation Oncology, Memorial Sloan Kettering, 1275 York Ave, New York, NY 10065, USA
    Radiat Oncol 8:99. 2013
    ..We examined the safety and efficacy of thoracic re-irradiation using high-precision image-guided stereotactic body radiation therapy (SBRT)...
  3. doi request reprint Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy
    Alice Y Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 118:4944-52. 2012
    ..The authors evaluated the clinical characteristics, natural history, and outcomes of patients who had ≤1 cm, lymph node-negative, triple-negative breast cancer (TNBC)...
  4. doi request reprint Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation
    Alice Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 118:2552-9. 2012
    ..The long-term rates of permanent implant removal or replacement (PIRR) and clinical outcomes in patients treated with a uniform reconstructive surgery and radiation regimen were evaluated...
  5. doi request reprint The effect of age in the outcome and treatment of older women with ductal carcinoma in situ
    Alice Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Breast 20:71-7. 2011
    ..00001) but not age. It is possible to identify older women with DCIS in whom the risk of recurrence is acceptably low after WLE alone. WLE alone may be a viable treatment option for select older women with DCIS...
  6. doi request reprint Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment
    Sarah Milgrom
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:3762-70. 2012
    ..Our aims were to evaluate the characteristics and outcomes of SLNB-positive TM patients who did not receive axillary-specific treatment and to compare them to similar patients who underwent breast-conserving surgery (BCS)...
  7. doi request reprint Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection
    Jeremy Setton
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 118:1994-2003. 2012
    ..The additional value of axillary radiotherapy in these patients is unknown...
  8. ncbi request reprint Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes
    Tracy Ann Moo
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:3169-74. 2013
    ..We examined clinicopathologic criteria used for PMRT selection and compared locoregional recurrence (LRR), recurrence-free survival (RFS), and overall survival (OS) among patients with and without PMRT...
  9. doi request reprint Patterns of utilization of adjuvant radiotherapy and outcomes in black women after breast conservation at a large multidisciplinary cancer center
    Sophia M Edwards-Bennett
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 80:1102-8. 2011
    ....
  10. doi request reprint Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer
    Ana P Kiess
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 118:1982-8. 2012
    ..In this sequential, retrospective study, the authors evaluated whether adjuvant trastuzumab was associated with reduced LRR in women with lymph node-negative, HER2-positive disease who received breast-conservation therapy (BCT)...
  11. ncbi request reprint Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes
    Tracy Ann Moo
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 21:1569-74. 2014
    ..We examined the association between MST and LRR, recurrence-free survival (RFS), and overall survival (OS), in T1-T2 tumors with 1-3 positive ALNs...
  12. pmc The evolution of the locoregional therapy of breast cancer
    Alice Ho
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Oncologist 16:1367-79. 2011
    ..The combination of the smaller cancers detected with screening and the routine use of multimodality therapy has resulted in a decrease in the morbidity of local therapy and improved cancer treatment outcomes...
  13. ncbi request reprint Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy
    Melissa Pilewskie
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 21:1209-14. 2014
    ..LR rates vary by subtype, with the highest rates seen in triple-negative breast cancer (TNBC). This study examined LR rates in relationship to margin width in TNBC treated with BCT...
  14. doi request reprint Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation
    Yong Hannah Wen
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Breast Cancer Res Treat 135:93-102. 2012
    ..Our results document substantial expression of Id4 in most TNBCs, which could result in functional downregulation of BRCA1 pathways in these tumors...
  15. doi request reprint The evolving role of partial breast irradiation in early-stage breast cancer
    Mitchel Barry
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:2534-40. 2013
    ..We review the evidence supporting APBI from modern clinical trials, the pros and cons of various APBI techniques, and the controversies regarding the applicability of APBI to specific patient groups. ..
  16. doi request reprint The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer
    Matthew Pugliese
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg 200:368-73. 2010
    ..Modern surgical and pathological techniques can detect small-volume axillary metastases in breast cancer with unknown clinical significance...